89bio Stock (NASDAQ:ETNB), Quotes and News Summary

Q: What sector and industry does 89bio (ETNB) operate in?

89bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

89bio Stock (NASDAQ: ETNB) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.272M
Day Range	- - -
52 Wk Range	6.575 - 22.930
Market Cap	$817.028M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	16.12%
Days to Cover	11.77

Recent News

Over $20M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.

Avi Kapoor

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.

Avi Kapoor

Liver Disease Player 89Bio Downgraded: Analyst Sees Short-Term Uncertainties In Fatty Liver Drug Development

89Bio's journey in the clinical-stage biopharmaceutical space. RBC Capital Markets downgrades with insights on FGF21 drugs, pegozafermin, and 2024 uncertainties.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Dec 23

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About 89bio Inc

Sector

Health Care

Industry

Biotechnology

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the developme...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy 89bio (ETNB) stock?

You can purchase shares of 89bio (NASDAQ: ETNB) through any online brokerage.

View our list of the best stock brokerages.

Who are 89bio's (ETNB) competitors?

Other companies in 89bio’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), Zentalis Pharma (NASDAQ:ZNTL), Cogent Biosciences (NASDAQ:COGT) and Sage Therapeutics (NASDAQ:SAGE).

What is the target price for 89bio (ETNB) stock?

The latest price target for 89bio (NASDAQ: ETNB) was reported by B of A Securities on Monday, April 22, 2024. The analyst firm set a price target for 30.00 expecting ETNB to rise to within 12 months (a possible 249.65% upside). 28 analyst firms have reported ratings in the last year.

Current Stock Price for 89bio (ETNB)?

The stock price for 89bio (NASDAQ: ETNB) is $8.58 last updated April 24, 2024 at 4:03 PM EDT.

Does 89bio (ETNB) pay a dividend?

There are no upcoming dividends for 89bio.

When is 89bio (NASDAQ:ETNB) reporting earnings?

89bio’s Q1 earnings are confirmed for Monday, May 6, 2024.

Is 89bio (ETNB) going to split?

There is no upcoming split for 89bio.

What sector and industry does 89bio (ETNB) operate in?

89bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-